Vermillion & White Wealth Management Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7	Closed	-$2	–	559
2024 Q4	$2	Hold	7	–	–	﹤0.01%	386
2024 Q3	$26	Sell	7 -1	-13%	-$6	﹤0.01%	348
2024 Q2	$73	Hold	8	–	–	﹤0.01%	369
2024 Q1	$588	Buy	+8	New	+$1.05K	﹤0.01%	327

Vermillion & White Wealth Management Group's SEEL Position: Q1 2025 in Review

Vermillion & White Wealth Management Group sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2025, closing a stake of 7 shares — an estimated $2 sold.

Vermillion & White Wealth Management Group first reported a position in SEEL in Q1 2024 and held it in 4 quarters. The position peaked at $588 in Q1 2024. 0 funds tracked by Wall St. Rank hold SEEL as of Q1 2025.

Vermillion & White Wealth Management Group reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 7 Seelos Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $2.
Vermillion & White Wealth Management Group first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
Vermillion & White Wealth Management Group's Seelos Therapeutics, Inc. Common Stock position peaked at $588 in Q1 2024.
0 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2025, filed 15 May 2025.